Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19457253 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Ticilimumab (CP-675,206) in Treating Patients With Stage IIIC or Stage IV Melanoma
Condition: Melanoma (Skin)
Intervention: Biological: CP-675,206

Indicates status has not been verified in more than two years